JP2014532754A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532754A5
JP2014532754A5 JP2014540612A JP2014540612A JP2014532754A5 JP 2014532754 A5 JP2014532754 A5 JP 2014532754A5 JP 2014540612 A JP2014540612 A JP 2014540612A JP 2014540612 A JP2014540612 A JP 2014540612A JP 2014532754 A5 JP2014532754 A5 JP 2014532754A5
Authority
JP
Japan
Prior art keywords
oxo
dihydro
compound
ylmethyl
oxazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540612A
Other languages
English (en)
Japanese (ja)
Other versions
JP6030146B2 (ja
JP2014532754A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/056236 external-priority patent/WO2013068948A1/en
Publication of JP2014532754A publication Critical patent/JP2014532754A/ja
Publication of JP2014532754A5 publication Critical patent/JP2014532754A5/ja
Application granted granted Critical
Publication of JP6030146B2 publication Critical patent/JP6030146B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540612A 2011-11-08 2012-11-07 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体 Expired - Fee Related JP6030146B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2011054968 2011-11-08
IBPCT/IB2011/054968 2011-11-08
PCT/IB2012/056236 WO2013068948A1 (en) 2011-11-08 2012-11-07 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Publications (3)

Publication Number Publication Date
JP2014532754A JP2014532754A (ja) 2014-12-08
JP2014532754A5 true JP2014532754A5 (enExample) 2015-12-03
JP6030146B2 JP6030146B2 (ja) 2016-11-24

Family

ID=47258051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540612A Expired - Fee Related JP6030146B2 (ja) 2011-11-08 2012-11-07 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体

Country Status (21)

Country Link
US (1) US9079922B2 (enExample)
EP (1) EP2776431B1 (enExample)
JP (1) JP6030146B2 (enExample)
KR (1) KR20140096337A (enExample)
AR (1) AR088691A1 (enExample)
AU (1) AU2012335207B2 (enExample)
BR (1) BR112014011064A8 (enExample)
CA (1) CA2854264A1 (enExample)
CL (1) CL2014001154A1 (enExample)
ES (1) ES2581056T3 (enExample)
HK (1) HK1202288A1 (enExample)
IL (1) IL232463A0 (enExample)
IN (1) IN2014CN04126A (enExample)
MX (1) MX344529B (enExample)
PH (1) PH12014500831A1 (enExample)
PL (1) PL2776431T3 (enExample)
RU (1) RU2616609C2 (enExample)
SG (1) SG11201401710PA (enExample)
TW (1) TWI594996B (enExample)
WO (1) WO2013068948A1 (enExample)
ZA (1) ZA201404176B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101294962B1 (ko) 2008-10-07 2013-08-12 액테리온 파마슈티칼 리미티드 트리사이클 옥사졸리디논 항생제 화합물
EA029361B1 (ru) 2013-04-16 2018-03-30 Идорсиа Фармасьютиклз Лтд Антибактериальные биароматические производные
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
MA41169A (fr) 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
US10487093B2 (en) 2016-02-08 2019-11-26 Redx Pharma Plc Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
EP3414246A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Antibacterial compounds
DK3468975T3 (da) 2016-06-08 2020-07-13 Acraf Nye antibakterielle forbindelser
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
EP3634968B1 (en) * 2017-06-08 2023-01-25 Bugworks Research, Inc. Heterocyclic compounds useful as anti-bacterial agents and method for production thereof
WO2019106693A1 (en) * 2017-11-29 2019-06-06 Bugworks Research India Pvt Ltd Anti-bacterial heterocyclic compounds and their synthesis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
CA1006521A (en) 1972-12-18 1977-03-08 Minoru Sugita Piperazine derivatives and process for preparing them
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
GB1598915A (en) 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
CS274601B2 (en) 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体
FI871419L (fi) 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
JP2631854B2 (ja) 1987-12-23 1997-07-16 藤本製薬株式会社 新規な1,8−ナフチリジン誘導体
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JPWO2004002973A1 (ja) 2002-06-28 2005-10-27 株式会社カネカ 光学活性1−置換アミノ−2,3−エポキシプロパンの製造方法並びにその合成中間体およびそれらの製造方法
ES2308171T3 (es) * 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
CA2549675C (en) * 2003-12-18 2012-11-20 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
EP1771456A2 (fr) 2004-07-30 2007-04-11 Palumed SA Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
CA2578081A1 (en) 2004-09-01 2006-03-09 Ubitrak Inc. System for gaming chip identification and counting
US20090156577A1 (en) 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
WO2007118130A2 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Antibacterial agents
ATE544764T1 (de) * 2006-11-10 2012-02-15 Actelion Pharmaceuticals Ltd 5-hydroxymethyloxazolidin-2-onderivate
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
RU2492169C2 (ru) * 2007-12-18 2013-09-10 Актелион Фармасьютиклз Лтд Производные 5-аминоциклилметилоксазолидин-2-она
JP5404652B2 (ja) * 2008-02-22 2014-02-05 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジノン誘導体
KR101294962B1 (ko) 2008-10-07 2013-08-12 액테리온 파마슈티칼 리미티드 트리사이클 옥사졸리디논 항생제 화합물
CA2738775A1 (en) * 2008-10-10 2010-04-15 Actelion Pharmaceuticals Ltd 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
MX2011003188A (es) * 2008-10-10 2011-04-27 Actelion Pharmaceuticals Ltd Antibioticos de oxazolidinilo.
TW201121965A (en) 2009-09-28 2011-07-01 Lg Life Sciences Ltd Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN101792443A (zh) 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途

Similar Documents

Publication Publication Date Title
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
RU2501799C2 (ru) Поизводные оксазолидинона
TWI248932B (en) Respiratory syncytial virus replication inhibitors
JP2005525324A5 (enExample)
JP2013539777A5 (enExample)
JP2014513110A5 (enExample)
JP2009534386A5 (enExample)
JP2017515844A5 (enExample)
JP2016512511A5 (enExample)
JP2013545798A5 (enExample)
JP2014525432A5 (enExample)
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
JP2017504611A5 (enExample)
JP2015514808A5 (enExample)
JP2010265321A5 (enExample)
JP2010132677A5 (enExample)
JP2010510999A5 (enExample)
JP2012515787A5 (enExample)
JP2016511262A5 (enExample)
JP2020512337A5 (enExample)
JP2012515788A5 (enExample)
JP2020529998A5 (enExample)
JP2016539157A5 (enExample)
RU2009121812A (ru) Производные 5-гидроксиметилоксазолидин-2-она
JP2016512507A5 (enExample)